Glucose Metabolism in Cardiovascular Diseases
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Endocrinology and Clinical Metabolic Research".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 59
Special Issue Editors
Interests: interventional cardiology; vascular intervention; glucose and lipid metabolism; muscle mitochondrial bioenergetics; IoT
Special Issue Information
Dear Colleagues,
The Special Issue will explore various topics relating to glucose metabolism and its implications for cardiovascular health. These topics include the longstanding issues historically associated with cardiovascular disease risk factors, the relationship between statin medications affecting mitochondrial function and potentially leading to glucose metabolism, and the potential of glucose intolerance to contribute to heart failure. Additionally, the issue will delve into the effects of MRA, beta-blockers, SGLT-2 inhibitors, and ARNI medications, often dubbed the “Fantastic Four”, on glucose metabolism and cardiovascular outcomes. Lastly, this Special Issue will discuss the integration of IoT technologies for improving the management of cardiovascular health and glucose metabolism, offering insights into innovative approaches for real-time monitoring and personalized interventions. With IoT devices, with the capability of capturing daily activity, the detection of muscle wastage can be performed, which is crucial as it may exacerbate insulin resistance and affect glucose tolerance, thereby posing additional challenges in managing risks. By addressing these topics comprehensively, the Special Issue can provide valuable insights into the complex interplay between glucose metabolism, cardiovascular disease, and therapeutic interventions, thus offering new perspectives and strategies for optimizing patient outcomes.
Dr. Hidenori Komiyama
Prof. Dr. Kuniya Asai
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- glucose metabolism
- insulin resistance
- statin use
- mitochondrial function
- heart failure
- IoT devices
- daily activity
- skeletal muscle
